results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.6/2018, held on August 10, 2018, has approved the financial statements of the

year, due mainly to a one-time gain from the sale of assets in the second quarter of 2019 and the impact from of the COVID-19 pandemic mentioned above. On 11 August 2020, the meeting of the Board of

expenses to support job expansion, employee bonus, audit fee, internal audit fee, meeting allowance and other compensation for directors. Theses are expenses related to the preparation for listing on the

is mainly due to increasing in employee salary expenses to support job expansion, employee bonus, audit fee, internal audit fee, meeting allowance and other compensation for directors. Theses are

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

- Part 2.3.9 Internal Control and Related Party Transaction (Q3) - As of 31Jan22 02 กุมภาพันธ์ 2565 [เอกสารแนบอื่น ๆ] 12. Solar - Attachment 1 - Directors and Management (Q3) - As of 31Jan22 02 กุมภาพันธ์

the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares to investors in private placement, the acquisition of assets and convening the

น ้ามนัดิบ เป็น https://www.sec.or.th/TH/Documents/Fund%20Manager/7.pdf 1 ( Translation ) Ref. NEP146-2017 October 25, 2017 Subject : Resolutions of the Board of Directors approving the capital

assets in the capital maintenance reports;  (2) had concealed business control power and lacked good corporate governance by allowing the person, who was neither a company’s director, executive, nor staff